2000
Atovaquone and Azithromycin for the Treatment of Babesiosis
Krause P, Lepore T, Sikand V, Gadbaw J, Burke G, Telford S, Brassard P, Pearl D, Azlanzadeh J, Christianson D, McGrath D, Spielman A. Atovaquone and Azithromycin for the Treatment of Babesiosis. New England Journal Of Medicine 2000, 343: 1454-1458. PMID: 11078770, DOI: 10.1056/nejm200011163432004.Peer-Reviewed Original ResearchConceptsCommon adverse effectsTreatment of babesiosisAdverse reactionsAdverse effectsCourse of clindamycinRegimen of clindamycinStart of therapyMalaria-like illnessPromising alternative treatmentStandard treatmentAlternative treatmentRegimenClindamycinAzithromycinAtovaquoneMonthsDiarrheaTreatmentBabesiosisQuinineSymptomsSubjectsPercentDaysBabesia microti DNA
1984
Occurrence of Clostridium difficile toxin-associated gastroenteritis following antibiotic therapy for otitis media in young children
HYAMS J, FEDER H, KRAUSE P, FRICK J, MCLAUGHLIN J, FURTH T, HINE P. Occurrence of Clostridium difficile toxin-associated gastroenteritis following antibiotic therapy for otitis media in young children. The Pediatric Infectious Disease Journal 1984, 3: 433-436. PMID: 6333674, DOI: 10.1097/00006454-198409000-00009.Peer-Reviewed Original ResearchConceptsToxin-positive stoolsOtitis mediaAntibiotic therapyAcute otitis mediaPathogenesis of diarrheaIncidence of diarrheaYoung childrenClostridium difficile toxinProspective studyDifficile toxinDiarrheaC. difficileOlder childrenFurther studiesPatientsStoolTherapyChildrenAge sixAge threeOutpatientsPathogenesisYearsGastroenteritisIncidence